Bli medlem
Bli medlem

Du är här


Probi: Increased number of shares and votes in Probi

As previously announced, Probi AB (publ) ("Probi") has carried out a
rights issue of no more than 2,278,825 shares. The 2,244,990 shares
subscribed for based on subscription rights have now been registered
with the Swedish Companies Registration Office, and the number of
shares and votes in the company have therefore increased in October

As of 31 October 2016, the total number of shares in Probi amounts to
11,610,290, corresponding to 11,610,290 votes.

This information is information that Probi AB is obliged to make
public pursuant to the Financial Instruments Trading Act.

Peter Nählstedt, CEO, Probi, tel +46 46 286 89 23, e-mail:

Niklas Brandt, CFO, Probi, tel +46 46 286 89 26, e-mail:

Probi AB is a Swedish publicly traded bioengineering company that
develops effective and well-documented probiotics. Through its
world-leading research, Probi has created a strong product portfolio
in the gastrointestinal health and immune system niches. Probi's
products are available to consumers in more than 30 countries
worldwide. Probi's customers are leading food, health-product and
pharmaceutical companies in the Functional Food and Consumer
Healthcare segments. In 2015 Probi had sales of MSEK 216. The Probi
share is listed on Nasdaq Stockholm, Small Cap. Probi has about 4,400
shareholders.


Författare WKR

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.